Annals of the Rheumatic Diseases 2021 Full Archives (True PDF)
Aims and Scope
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research.
Annals of the Rheumatic Diseases is the flagship of BMJ’s rheumatology portfolio and has two companion journals: RMD Open for original research in rheumatology and musculoskeletal disorders and Lupus Science & Medicine for original research in lupus and related diseases.
For information about the Annals of the Rheumatic Diseases Editor-in-Chief Prof Josef Smolen and his editorial team, please refer to the Editorial Board page.
Plan S compliance
Annals of the Rheumatic Diseases is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
|Ownership||ARD is co-owned by the European Alliance of Associations for Rheumatology (EULAR) and BMJ.|
|Digital Archives||Portico, LOCKSS|
|Indexed by||Web of Science Core Collection|
|Peer Review Model||Single blind; the names of reviewers are hidden from the author|
Vol 80, Issue 12
Vol 80, Issue 11
Vol 80, Issue 10
Vol 80, Issue 9
Vol 80, Issue 8
Vol 80, Issue 7
Vol 80, Issue 6
Vol 80, Issue 5
Vol 80, Issue 4
Vol 80, Issue 3
Vol 80, Issue 2
Vol 80, Issue 1